UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
1351
Summit Hotel Properties
INN
$670M
| $2.95M | ﹤0.01% |
438,356
+3,079
| +0.7% | +$24.1K |
|
1352
GATX Corp
GATX
$6.23B
| $2.93M | ﹤0.01% |
34,460
-10,540
| -23% | -$1.02M |
|
1353
Arcosa
ACA
$7.11B
| $2.93M | ﹤0.01% |
51,206
-10,213
| -17% | -$566K |
|
1354
Unifirst Corp
UNF
$5.24B
| $2.91M | ﹤0.01% |
17,315
-3,956
| -19% | -$722K |
|
|
GAP
1355
The Gap Inc
GAP
$7.74B
| $2.91M | ﹤0.01% |
354,489
-52,067
| -13% | -$489K |
|
|
COOP
1356
DELISTED
Mr. Cooper
COOP
| $2.91M | ﹤0.01% |
71,799
-13,689
| -16% | -$579K |
|
1357
Meritage Homes
MTH
$4.69B
| $2.9M | ﹤0.01% |
82,430
-16,182
| -16% | -$655K |
|
1358
Avient
AVNT
$4.19B
| $2.89M | ﹤0.01% |
95,461
-19,396
| -17% | -$804K |
|
1359
Diageo
DEO
$54B
| $2.89M | ﹤0.01% |
17,028
+100
| +0.6% | +$17.9K |
|
1360
Spectrum Brands
SPB
$2.02B
| $2.89M | ﹤0.01% |
74,061
-4,218
| -5% | -$272K |
|
1361
UiPath
PATH
$8.08B
| $2.88M | ﹤0.01% |
228,142
-20,289
| -8% | -$356K |
|
1362
NETSCOUT
NTCT
$2.81B
| $2.87M | ﹤0.01% |
91,560
-10,335
| -10% | -$338K |
|
|
AXNX
1363
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.86M | ﹤0.01% |
40,671
-10,807
| -21% | -$745K |
|
1364
Arrowhead Research
ARWR
$12.5B
| $2.85M | ﹤0.01% |
86,360
-23,365
| -21% | -$943K |
|
1365
Privia Health
PRVA
$2.86B
| $2.85M | ﹤0.01% |
83,790
+12,479
| +17% | +$461K |
|
1366
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.18B
| $2.85M | ﹤0.01% |
95,112
-33,926
| -26% | -$1.27M |
|
1367
ABM Industries
ABM
$2.81B
| $2.84M | ﹤0.01% |
74,344
-17,431
| -19% | -$763K |
|
1368
BellRing Brands
BRBR
$1.32B
| $2.83M | ﹤0.01% |
137,354
-20,664
| -13% | -$496K |
|
1369
Cathay General Bancorp
CATY
$4.23B
| $2.82M | ﹤0.01% |
73,437
-149,981
| -67% | -$6.24M |
|
1370
Ginkgo Bioworks
DNA
$500M
| $2.82M | ﹤0.01% |
22,568
-4,985
| -18% | -$594K |
|
1371
Innospec
IOSP
$2.29B
| $2.81M | ﹤0.01% |
32,813
-4,093
| -11% | -$387K |
|
1372
Associated Banc-Corp
ASB
$5.92B
| $2.81M | ﹤0.01% |
139,789
-27,458
| -16% | -$552K |
|
|
HCP
1373
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $2.8M | ﹤0.01% |
87,120
+25,220
| +41% | +$871K |
|
1374
ATI
ATI
$31.1B
| $2.8M | ﹤0.01% |
105,333
-22,087
| -17% | -$615K |
|
1375
Beam Therapeutics
BEAM
$2.82B
| $2.8M | ﹤0.01% |
58,790
-6,578
| -10% | -$375K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.